BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

TLSI

TriSalus Life Sciences, Inc.
Nasdaq · Surgical & medical instruments & apparatus (SIC 3841) · FY ends 31 Dec

Revenue, quarterly

$11M+1.7% year on year
$15M$10M$5M$0
Q3 ’22Q3 ’23Q3 ’24Q2 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

85.8%+1.1 pp year on year
90%85%80%75%
Q2 ’23Q1 ’24Q4 ’24Q3 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$46M+74.7% year on year
$60M$40M$20M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$23M
$20M$0−$20M−$40M−$60M
Q3 ’23Q2 ’24Q1 ’25Q3 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty